Benzinga | Nov 9, 2020 04:17PM EST

Forte Biosciences, Inc. - Common Stock Q3 EPS $(0.45) Beats $(0.54) Estimate

Forte Biosciences, Inc. - Common Stock (NASDAQ:FBRX) reported quarterly losses of $(0.45) per share which beat the analyst consensus estimate of $(0.54) by 16.67 percent.